These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 6370431)

  • 1. Endogenous prostaglandin E2 metabolite levels, renin-angiotensin system and catecholamines versus acute hemodynamic response to captopril in chronic congestive heart failure.
    Silberbauer K; Punzengruber C; Sinzinger H
    Cardiology; 1983; 70(6):297-307. PubMed ID: 6370431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
    Kluger J; Cody RJ; Laragh JH
    Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
    Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
    Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation of the prostaglandin and renin angiotensin systems during captopril therapy for chronic congestive heart failure secondary to coronary artery disease.
    Dzau VJ; Swartz SL
    Am J Cardiol; 1987 Nov; 60(13):1101-5. PubMed ID: 3314460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral hemodynamic effects of captopril in patients with congestive heart failure.
    Nishimura H; Kubo S; Ueyama M; Kubota J; Kawamura K
    Am Heart J; 1989 Jan; 117(1):100-5. PubMed ID: 2643280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA; Waeber B; Brunner HR
    Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of captopril on cardiopulmonary hemodynamics and renin-angiotensin-aldosterone and bradykinin profile in hypertension.
    Mookherjee S; Anderson GH; Eich R; Hill N; Smulyan H; Streeten DH; Vardan S; Warner R
    Am Heart J; 1983 Jan; 105(1):106-12. PubMed ID: 6336874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and hormonal responses during captopril therapy for heart failure: acute, chronic and withdrawal studies.
    Nicholls MG; Ikram H; Espiner EA; Maslowski AH; Scandrett MS; Penman T
    Am J Cardiol; 1982 Apr; 49(6):1497-501. PubMed ID: 6803564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II levels, hemodynamics, and sympathoadrenal function after low-dose captopril in heart failure.
    Cleland J; Semple P; Hodsman P; Ball S; Ford I; Dargie H
    Am J Med; 1984 Nov; 77(5):880-6. PubMed ID: 6388325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
    Levine TB; Cohn JN
    Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of captopril in patients with severe chronic heart failure.
    LeJemtel TH; Keung E; Frishman WH; Ribner HS; Sonnenblick EH
    Am J Cardiol; 1982 Apr; 49(6):1484-8. PubMed ID: 7041587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition in congestive heart failure: the concept.
    Cohn JN; Levine TB
    Am J Cardiol; 1982 Apr; 49(6):1480-3. PubMed ID: 6176108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase in bicycloprostaglandin E2 metabolite in congestive heart failure in response to captopril.
    Stanek B; Punzengruber C; Silberbauer K
    Clin Cardiol; 1989 Feb; 12(2):97-101. PubMed ID: 2653680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertension.
    Muiesan G; Alicandri CL; Agabiti-Rosei E; Fariello R; Beschi M; Boni E; Castellano M; Moniti E; Muiesan L; Romanelli G; Zanielli A
    Am J Cardiol; 1982 Apr; 49(6):1420-4. PubMed ID: 6280474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of captopril on arterial and venous pressure, renal function, and humoral factors in severe chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    Clin Pharmacol Ther; 1984 Oct; 36(4):456-63. PubMed ID: 6206977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure.
    Cody RJ; Laragh JH
    Am Heart J; 1982 Nov; 104(5 Pt 2):1184-9. PubMed ID: 6291364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandins in severe congestive heart failure. Relation to activation of the renin--angiotensin system and hyponatremia.
    Dzau VJ; Packer M; Lilly LS; Swartz SL; Hollenberg NK; Williams GH
    N Engl J Med; 1984 Feb; 310(6):347-52. PubMed ID: 6361570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bicyclo-prostaglandin E2 metabolite in congestive heart failure and relation to vasoconstrictor neurohumoral principles.
    Punzengruber C; Stanek B; Sinzinger H; Silberbauer K
    Am J Cardiol; 1986 Mar; 57(8):619-23. PubMed ID: 3513522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin inhibition in severe heart failure: acute central and limb hemodynamic effects of captopril with observations on sustained oral therapy.
    Faxon DP; Halperin JL; Creager MA; Gavras H; Schick EC; Ryan TJ
    Am Heart J; 1981 May; 101(5):548-56. PubMed ID: 7013458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of captopril-induced renin release by angiotensin II.
    Mersey JH; Ceballos L; Swartz S
    J Cardiovasc Pharmacol; 1987 Nov; 10(5):575-9. PubMed ID: 2447408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.